p.5 抽出テキスト

............................................................................................................................................................................. Table 7 Causes of elevated concentrations of natriuretic peptides . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3618 Table 8 Evidence-based doses of disease-modifying drugs in key randomized trials in patients with heart failure with reduced ejection fraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3621 Table 9 Objective evidence of cardiac structural, functional and serological abnormalities consistent with the presence of left ventricular diastolic dysfunction/raised left ventricular filling pressures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3631 Table 10 Risk factors for the development of heart failure and potential corrective actions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3632 Table 11 Important characteristics and components in a heart failure management programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3634 Table 12 Patient education and self-care . . . . . . . . . . . . . . . . . . . . . . . . . . 3634 Table 13 Criteria for definition of advanced heart failure . . . . . . . . . . . 3638 Table 14 Interagency Registry for Mechanically Assisted Circulatory Support profile descriptions of patients with advanced heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3638 Table 15 Terms describing various indications for mechanical circulatory support . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3642 Table 16 Patients potentially eligible for implantation of a left ventricular assist device . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3642 Table 17 Heart transplantation: indications and contraindications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3643 Table 18 Patients with heart failure in whom end-of-life care should be considered . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3644 Table 19 Key components of palliative care service in patients with advanced heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3644 Table 20 Diagnostic tests in patients with acute heart failure . . . . . . . 3646 Table 21 Clinical presentations of acute heart failure . . . . . . . . . . . . . . 3647 Table 22 Inotropes and/or vasopressors used to treat acute heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3655 Table 23 Cancer drugs causing heart failure . . . . . . . . . . . . . . . . . . . . . . . 3673 Table 24 Infections in patients with heart failure . . . . . . . . . . . . . . . . . . . 3675 Table 25 Possible causes and disease modifiers of most frequent cardiomyopathies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3678 Table 26 Initial diagnostic assessment in patients with suspected cardiomyopathy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3678 Table 27 Dilated cardiomyopathy or hypokinetic non-dilated cardiomyopathy: specific aspects of diagnosis and treatment . . . . . . . 3679 Table 28 Hypertrophic cardiomyopathy: specific aspects of diagnosis and treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3680 Table 29 Arrhythmogenic cardiomyopathy: specific aspects of diagnosis and Treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3681 Table 30 Aetiologies to be considered triggering acute myocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3682 Table 31 Diagnostic workup in suspected acute myocarditis . . . . . . . 3683 Table 32 Endomyocardial biopsy in patients with suspected myocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3684 Table 33 Cardiac magnetic resonance in patients with suspected myocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3685 Table 34 Treatment and follow-up of acute myocarditis . . . . . . . . . . . 3685 Table 35 “Red flags” for most common forms of cardiac amyloidosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3686 Table 36 Treatment of adult congenital heart disease and heart failure in specialized centres . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3688 Table 37 Main European Society of Cardiology Quality Indicators for the evaluation of care and outcomes for patients with heart failure . 3693

List of figures

Figure 1 The diagnostic algorithm for heart failure . . . . . . . . . . . . . . . . . 3615 Figure 2 Therapeutic algorithm of Class I Therapy Indications for a patient with heart failure with reduced ejection fraction . . . . . . . . . . . 3620 Figure 3 Central illustration Strategic phenotypic overview of the management of heart failure with reduced ejection fraction . . . . . . . . 3624 Figure 4 Algorithm for the treatment of patients with advanced heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3640 Figure 5 Triage of patients with advanced heart failure and appropriate timing of referral . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3641 Figure 6 Diagnostic workup of new onset acute heart failure . . . . . . . 3645 Figure 7 Management of acute decompensated heart failure . . . . . . . 3648 Figure 8 Management of pulmonary oedema . . . . . . . . . . . . . . . . . . . . . . 3649 Figure 9 Management of right ventricular failure . . . . . . . . . . . . . . . . . . . 3650 Figure 10 Management of cardiogenic shock . . . . . . . . . . . . . . . . . . . . . . 3651 Figure 11 Stages of management of patients with acute heart failure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3652 Figure 12 Initial management of acute heart failure . . . . . . . . . . . . . . . . 3653 Figure 13 Diuretic therapy (furosemide) in acute heart failure . . . . . . 3654 Figure 14 Management of atrial fibrillation in patients with heart failure with reduced ejection fraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3658 Figure 15 Algorithm for the medical treatment of chronic coronary syndrome in patients with heart failure with reduced ejection fraction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3661 Figure 16 Management of patients with severe low-flow low-gradient aortic stenosis and heart failure . . . . . . . . . . . . . . . . . . . . . 3663 Figure 17 Management of secondary mitral regurgitation in patients with heart failure with reduced ejection fraction . . . . . . . . . . . . . . . . . . 3664 Figure 18 Management of patients with cancer and heart failure . . . . 3674 Figure 19 Management of patients with heart failure before and during pregnancy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3676 Figure 20 Management of patients with heart failure and acute myocarditis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3684 Figure 21 Diagnosis and treatment of cardiac amyloidosis in heart failure patients . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3687

Abbreviations and acronyms

6MWT 6-minute walk test 99mTc-PYP Technetium-labelled pyrophosphate AATAC Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD (trial) AC Arrhythmogenic cardiomyopathy ACE Angiotensin-converting enzyme ACE-I Angiotensin-converting enzyme inhibitor ACHD Adult congenital heart disease ACS Acute coronary syndrome ADHF Acutely decompensated heart failure AF Atrial fibrillation AF-CHF Atrial fibrillation  Congestive Heart Failure (trial) Downloaded from academic.oup.com/eurheartj/article/42/36/3599/6358045 by guest on 07 October 2026